| Primary |
| Atrial Fibrillation |
36.9% |
| Arrhythmia |
7.8% |
| Pulmonary Embolism |
6.8% |
| Pain |
5.8% |
| Prophylaxis |
5.8% |
| Hypertension |
4.9% |
| Depression |
3.9% |
| Type 2 Diabetes Mellitus |
3.9% |
| Arrhythmia Supraventricular |
2.9% |
| Deep Vein Thrombosis |
2.9% |
| Cardiac Flutter |
1.9% |
| Cardiomyopathy |
1.9% |
| Diarrhoea |
1.9% |
| Gout |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Lung Disorder |
1.9% |
| Pulmonary Arterial Hypertension |
1.9% |
| Respiratory Tract Congestion |
1.9% |
| Urinary Tract Infection |
1.9% |
| Acute Respiratory Failure |
1.0% |
|
| Subdural Haematoma |
14.5% |
| Rectal Haemorrhage |
11.3% |
| Renal Failure Acute |
11.3% |
| Overdose |
9.7% |
| Shock Haemorrhagic |
9.7% |
| International Normalised Ratio Increased |
8.1% |
| Vomiting |
4.8% |
| Cholestasis |
3.2% |
| Haematoma |
3.2% |
| Melaena |
3.2% |
| Muscle Haemorrhage |
3.2% |
| Renal Failure |
3.2% |
| Transient Ischaemic Attack |
3.2% |
| Deep Vein Thrombosis |
1.6% |
| Diarrhoea |
1.6% |
| Disturbance In Attention |
1.6% |
| Feeling Abnormal |
1.6% |
| Gastrointestinal Haemorrhage |
1.6% |
| Gingival Bleeding |
1.6% |
| Haemoglobin Decreased |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
48.2% |
| Atrial Fibrillation |
7.2% |
| Deep Vein Thrombosis |
7.2% |
| Arrhythmia Supraventricular |
5.0% |
| Arrhythmia |
4.7% |
| Pulmonary Embolism |
2.9% |
| Depression |
2.5% |
| Pulmonary Arterial Hypertension |
2.5% |
| Atrial Tachycardia |
2.2% |
| Nausea |
2.2% |
| Palpitations |
2.2% |
| Diarrhoea |
1.8% |
| Hypertension |
1.8% |
| Acute Sinusitis |
1.4% |
| Analgesic Therapy |
1.4% |
| Breast Cancer |
1.4% |
| Diabetic Neuropathy |
1.4% |
| Neuroendocrine Tumour |
1.4% |
| Vitamin D Deficiency |
1.4% |
| Antiphospholipid Syndrome |
1.1% |
|
| Renal Failure Acute |
8.3% |
| Weight Increased |
8.3% |
| Drug Interaction |
6.7% |
| Haematoma |
6.7% |
| Interstitial Lung Disease |
6.7% |
| Melaena |
6.7% |
| Multi-organ Failure |
6.7% |
| International Normalised Ratio Increased |
5.0% |
| Rhabdomyolysis |
5.0% |
| Right Ventricular Failure |
5.0% |
| Thrombocytopenia |
5.0% |
| Drug Hypersensitivity |
3.3% |
| Intra-abdominal Haematoma |
3.3% |
| Muscle Haemorrhage |
3.3% |
| Renal Failure |
3.3% |
| Thrombocytopenic Purpura |
3.3% |
| Toxic Skin Eruption |
3.3% |
| Vascular Purpura |
3.3% |
| Vomiting |
3.3% |
| Wound |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.3% |
| Hypertension |
13.0% |
| Cardiac Failure |
10.2% |
| Atrial Fibrillation |
6.8% |
| Pain |
6.2% |
| Pulmonary Hypertension |
4.1% |
| Rheumatoid Arthritis |
3.4% |
| Anticoagulant Therapy |
3.2% |
| Plasma Cell Myeloma |
3.2% |
| Pulmonary Arterial Hypertension |
2.9% |
| Breast Cancer |
2.4% |
| Osteoporosis |
2.4% |
| Blood Pressure Abnormal |
2.3% |
| Drug Use For Unknown Indication |
2.3% |
| Multiple Sclerosis |
2.3% |
| Cardiac Disorder |
2.1% |
| Prophylaxis |
2.1% |
| Chronic Myeloid Leukaemia |
1.9% |
| Depression |
1.9% |
| Hiv Infection |
1.9% |
|
| Renal Failure Acute |
13.4% |
| Weight Decreased |
9.2% |
| Vomiting |
8.4% |
| Somnolence |
6.7% |
| Wheezing |
6.7% |
| Death |
5.9% |
| Mitral Valve Incompetence |
5.0% |
| Off Label Use |
4.2% |
| Weight Increased |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Fall |
3.4% |
| Hepatocellular Injury |
3.4% |
| Hyponatraemia |
3.4% |
| Neutropenia |
3.4% |
| Rash |
3.4% |
| Thrombosis |
3.4% |
| Tremor |
3.4% |
| Urinary Tract Infection |
3.4% |
| Agranulocytosis |
2.5% |
| Malaise |
2.5% |
|
| Interacting |
| Product Used For Unknown Indication |
12.7% |
| Prophylaxis |
12.7% |
| Helicobacter Infection |
11.3% |
| Atrial Fibrillation |
8.5% |
| Cardiac Valve Disease |
7.0% |
| Pain |
7.0% |
| Depression |
5.6% |
| Deep Vein Thrombosis |
4.2% |
| Dyslipidaemia |
4.2% |
| Urinary Tract Infection |
4.2% |
| Anxiety |
2.8% |
| Cerebrovascular Accident Prophylaxis |
2.8% |
| International Normalised Ratio Abnormal |
2.8% |
| Oesophageal Candidiasis |
2.8% |
| Rheumatic Fever |
2.8% |
| Wound Infection |
2.8% |
| Anticoagulant Therapy |
1.4% |
| Discomfort |
1.4% |
| Gastroduodenal Ulcer |
1.4% |
| Hypertension |
1.4% |
|
| International Normalised Ratio Increased |
14.8% |
| Overdose |
14.8% |
| Subdural Haematoma |
11.1% |
| Drug Interaction |
7.4% |
| International Normalised Ratio Decreased |
7.4% |
| Peripheral Vascular Disorder |
7.4% |
| Hypotension |
3.7% |
| International Normalised Ratio Abnormal |
3.7% |
| Ligament Injury |
3.7% |
| Mouth Haemorrhage |
3.7% |
| Muscle Haemorrhage |
3.7% |
| Normochromic Normocytic Anaemia |
3.7% |
| Osteoarthritis |
3.7% |
| Rectal Haemorrhage |
3.7% |
| Renal Failure Acute |
3.7% |
| Vomiting |
3.7% |
|
